Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-079982
Filing Date
2016-02-09
Accepted
2016-02-09 16:19:13
Documents
94
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v430167_10q.htm 10-Q 783858
2 EXHIBIT 31.1 v430167_ex31-1.htm EX-31.1 13639
3 EXHIBIT 31.2 v430167_ex31-2.htm EX-31.2 13803
4 EXHIBIT 32.1 v430167_ex32-1.htm EX-32.1 5459
5 EXHIBIT 32.2 v430167_ex32-2.htm EX-32.2 5447
  Complete submission text file 0001144204-16-079982.txt   6932184

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eltp-20151231.xml EX-101.INS 1949030
7 XBRL TAXONOMY EXTENSION SCHEMA eltp-20151231.xsd EX-101.SCH 60378
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20151231_cal.xml EX-101.CAL 48063
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20151231_def.xml EX-101.DEF 305034
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20151231_lab.xml EX-101.LAB 343322
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20151231_pre.xml EX-101.PRE 364493
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 161399926
SIC: 2834 Pharmaceutical Preparations